tradingkey.logo
tradingkey.logo
Search

Aeon Biopharma Inc

AEON
Add to Watchlist
0.298USD
+0.043+16.81%
Close 07-31 16:00ETQuotes delayed by 15 min
7.54MMarket Cap
LossP/E TTM

AEON Financials

See Aeon Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Aeon Biopharma Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.29/--
Revenue / Forecast
--/--
Period
FY2026 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.29
92.66%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
-112.72%-0.29
-176.84%-2.88
96.53%-0.39
-100.20%-0.60
101.00%2.28
100.50%3.75
-114.93%-11.24
1120.74%304.20
-567.06%-228.00
-1029.67%-756.61
--75.32
---29.80
---34.18
---66.98
---34.87
----
----
Net Profit
-229.66%-11.79M
-1883.72%-37.14M
26.46%-4.54M
-104.05%-6.64M
107.71%9.10M
100.53%2.08M
-115.87%-6.17M
1167.12%164.11M
-569.07%-118.02M
-1029.79%-390.49M
472.44%38.88M
-515.90%-15.38M
-248.87%-17.64M
---34.56M
---10.44M
---2.50M
---5.06M
Debt to assets ratio
-81.49%17.87%
67.27%622.30%
-48.47%195.23%
-43.87%130.11%
-42.47%96.53%
--372.02%
--378.87%
-94.03%231.81%
--167.78%
--0.00%
--0.00%
--3883.38%
----
----
----
----
----
Operating profit
-50.30%-5.94M
2.91%-5.50M
37.00%-2.53M
44.30%-4.32M
61.95%-3.95M
50.07%-5.67M
72.25%-4.02M
44.46%-7.76M
20.43%-10.38M
24.51%-11.35M
-45.98%-14.47M
-14.96%-13.97M
-15.17%-13.05M
---15.03M
---9.91M
---12.15M
---11.33M
Net Profit
-229.66%-11.79M
-1883.72%-37.14M
26.46%-4.54M
-104.05%-6.64M
107.71%9.10M
100.53%2.08M
-115.87%-6.17M
1167.12%164.11M
-569.07%-118.02M
-1029.79%-390.49M
472.44%38.88M
-515.90%-15.38M
-248.87%-17.64M
---34.56M
---10.44M
---2.50M
---5.06M
Current assets
-46.23%6.63M
113.71%3.40M
212.61%7.41M
155.34%10.26M
393.23%12.32M
-74.45%1.59M
-85.98%2.37M
50.98%4.02M
--2.50M
--6.22M
--16.91M
--2.66M
----
----
----
----
----
Total current liabilities
-22.81%6.67M
-51.25%6.90M
-23.29%8.23M
-12.47%9.13M
-45.85%8.64M
8.43%14.15M
-24.34%10.73M
-88.19%10.43M
--15.96M
--13.05M
--14.18M
--88.34M
----
----
----
----
----
Total assets
-37.46%8.63M
76.96%5.56M
118.13%8.73M
103.38%11.66M
355.11%13.80M
-54.10%3.14M
-77.27%4.00M
65.72%5.73M
--3.03M
--6.84M
--17.62M
--3.46M
----
----
----
----
----
Total liabilities
1.03%25.38M
91.06%60.59M
-20.75%28.61M
-18.31%27.51M
-87.53%25.12M
-80.17%31.71M
-74.10%36.09M
-77.46%33.68M
--201.41M
--159.89M
--139.36M
--149.40M
----
----
----
----
----
Total equity
-47.95%-16.75M
-92.61%-55.03M
38.07%-19.87M
43.28%-15.85M
94.29%-11.32M
81.33%-28.57M
73.64%-32.09M
80.85%-27.95M
---198.38M
---153.04M
---121.74M
---145.94M
----
----
----
----
----
Net operating income
66.67%-2.64M
-658.78%-4.71M
12.15%-2.60M
74.24%-2.09M
8.03%-7.91M
94.36%-621.00K
81.13%-2.96M
---8.12M
---8.60M
-30.34%-11.02M
-35.85%-15.66M
----
----
---8.45M
---11.53M
----
----
Net investment
100.00%0.00
--0.00
--0.00
--0.00
---4.00K
----
----
----
--0.00
100.00%0.00
100.00%0.00
----
----
---9.00K
---228.00K
----
----
Net financing
-67.99%5.87M
1746.39%1.79M
68.00%84.00K
-99.16%84.00K
266.92%18.35M
--97.00K
--50.00K
--10.00M
--5.00M
100.00%0.00
-100.00%0.00
----
----
---3.99M
--32.50M
----
----

FAQs

What are the current assets of Aeon Biopharma Inc?

According to Aeon Biopharma Inc's FY2026 earnings report, its current assets were 6.62M, with a year-on-year change of 94.97.

What are the total assets of Aeon Biopharma Inc?

According to Aeon Biopharma Inc's FY2026 earnings report, its total assets of Aeon Biopharma Inc were 8.63M, with a year-on-year change of 55.22.

What are the total liabilities of Aeon Biopharma Inc?

According to Aeon Biopharma Inc's FY2026 earnings report, its total liabilities of Aeon Biopharma Inc were 25.38M, with a year-on-year change of -58.11.

What is the total equity of Aeon Biopharma Inc?

According to Aeon Biopharma Inc's FY2026 earnings report, its total equity of Aeon Biopharma Inc was -16.75M, with a year-on-year change of 69.56.

What is the net operating income of Aeon Biopharma Inc?

According to Aeon Biopharma Inc's FY2026 earnings report, its net operating income of Aeon Biopharma Inc was -5.93M, with a year-on-year change of 63.61.

What is the net financing of Aeon Biopharma Inc?

According to Aeon Biopharma Inc's FY2026 earnings report, its net financing of Aeon Biopharma Inc was 20.30M, with a year-on-year change of 34.05.

What is the Earnings Per Share (EPS) of Aeon Biopharma Inc?

According to Aeon Biopharma Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -0.29, with a year-on-year change of 92.66.

What is the debt-to-asset ratio of Aeon Biopharma Inc?

According to Aeon Biopharma Inc's FY2026 earnings report, its debt-to-asset ratio was 17.87, with a year-on-year change of -97.13.

What is the operating profit of Aeon Biopharma Inc?

According to Aeon Biopharma Inc's FY2026 earnings report, its operating profit was -5.93M, with a year-on-year change of 63.61.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.